Zhida Pharmaceutical received tens of millions of RMB in Series A financing

Zhida Pharmaceutical is a nano drug delivery platform technology developer. Its core technologies include nanoliposome drug delivery platform, albumin nanoparticle drug delivery platform, peptide nano drug delivery platform and high-efficiency in vivo nucleic acid drug delivery platform, etc. At present, it has a GMP-validated nanoliposome drug production line. Recently, Zhida Pharmaceutical completed tens of millions of yuan in Series A strategic financing, exclusively completed by Sinopharm Zhongjin.

This article is reproduced from: https://www.itjuzi.com/investevent/13525779
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment